BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21292878)

  • 1. Antigenic diversity of the Plasmodium vivax circumsporozoite protein in parasite isolates of Western Colombia.
    Hernández-Martínez MÁ; Escalante AA; Arévalo-Herrera M; Herrera S
    Am J Trop Med Hyg; 2011 Feb; 84(2 Suppl):51-7. PubMed ID: 21292878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants of the Plasmodium vivax circumsporozoite protein (VK210 and VK247) in Colombian isolates.
    González JM; Hurtado S; Arévalo-Herrera M; Herrera S
    Mem Inst Oswaldo Cruz; 2001 Jul; 96(5):709-12. PubMed ID: 11500776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited genetic diversity in the global Plasmodium vivax Cell traversal protein of Ookinetes and Sporozoites (CelTOS) sequences; implications for PvCelTOS-based vaccine development.
    Mehrizi AA; Torabi F; Zakeri S; Djadid ND
    Infect Genet Evol; 2017 Sep; 53():239-247. PubMed ID: 28600217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the genetic diversity of domain II of Plasmodium vivax Apical Membrane Antigen 1 (PvAMA-1) and the ensuing strain-specific immune responses in patients from Sri Lanka.
    Dias S; Somarathna M; Manamperi A; Escalante AA; Gunasekera AM; Udagama PV
    Vaccine; 2011 Oct; 29(43):7491-504. PubMed ID: 21784116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites.
    Yadava A; Sattabongkot J; Washington MA; Ware LA; Majam V; Zheng H; Kumar S; Ockenhouse CF
    Infect Immun; 2007 Mar; 75(3):1177-85. PubMed ID: 17158893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic and genetic characterization of Plasmodium vivax from whole blood-impregnated filter paper discs.
    Kain KC; Wirtz RA; Fernandez I; Franke ED; Rodriguez MH; Lanar DE
    Am J Trop Med Hyg; 1992 Apr; 46(4):473-9. PubMed ID: 1575295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Plasmodium vivax VK210 and VK247 subtype in Myanmar.
    Kim TS; Kim HH; Lee SS; Na BK; Lin K; Cho SH; Kang YJ; Kim DK; Sohn Y; Kim H; Lee HW
    Malar J; 2010 Jul; 9():195. PubMed ID: 20615261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The population dynamics in mosquitoes and humans of two Plasmodium vivax polymorphs distinguished by different circumsporozoite protein repeat regions.
    Burkot TR; Wirtz RA; Paru R; Garner P; Alpers MP
    Am J Trop Med Hyg; 1992 Dec; 47(6):778-86. PubMed ID: 1471735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Plasmodium berghei transgenic parasite expressing the full-length Plasmodium vivax circumsporozoite VK247 protein for testing vaccine efficacy in a murine model.
    Mizutani M; Fukumoto S; Soubeiga AP; Soga A; Iyori M; Yoshida S
    Malar J; 2016 Apr; 15(1):251. PubMed ID: 27129682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population.
    Cheng Y; Ito D; Sattabongkot J; Lim CS; Kong DH; Ha KS; Wang B; Tsuboi T; Han ET
    Malar J; 2013 Sep; 12():323. PubMed ID: 24034268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenicity and immunogenicity of a novel chimeric peptide antigen based on the P. vivax circumsporozoite protein.
    Céspedes N; Arévalo-Herrera M; Felger I; Reed S; Kajava AV; Corradin G; Herrera S
    Vaccine; 2013 Oct; 31(42):4923-30. PubMed ID: 23954378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenicity and immunogenicity of a novel Plasmodium vivax circumsporozoite derived synthetic vaccine construct.
    Céspedes N; Jiménez E; Lopez-Perez M; Rubiano K; Felger I; Alonso P; Arévalo-Herrera M; Corradin G; Herrera S
    Vaccine; 2014 May; 32(26):3179-86. PubMed ID: 24731811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge.
    de Camargo TM; de Freitas EO; Gimenez AM; Lima LC; de Almeida Caramico K; Françoso KS; Bruna-Romero O; Andolina C; Nosten F; Rénia L; Ertl HCJ; Nussenzweig RS; Nussenzweig V; Rodrigues MM; Reyes-Sandoval A; Soares IS
    Sci Rep; 2018 Jan; 8(1):1118. PubMed ID: 29348479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low immunogenicity of a Plasmodium vivax circumsporozoite protein epitope bound by a protective monoclonal antibody.
    Jones TR; Yuan LF; Marwoto HA; Gordon DM; Wirtz RA; Hoffman SL
    Am J Trop Med Hyg; 1992 Dec; 47(6):837-43. PubMed ID: 1471743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea.
    Henry-Halldin CN; Sepe D; Susapu M; McNamara DT; Bockarie M; King CL; Zimmerman PA
    Infect Genet Evol; 2011 Mar; 11(2):391-8. PubMed ID: 21147267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global genetic diversity of the Plasmodium vivax transmission-blocking vaccine candidate Pvs48/45.
    Vallejo AF; Martinez NL; Tobon A; Alger J; Lacerda MV; Kajava AV; Arévalo-Herrera M; Herrera S
    Malar J; 2016 Apr; 15():202. PubMed ID: 27067024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens.
    Kain KC; Brown AE; Webster HK; Wirtz RA; Keystone JS; Rodriguez MH; Kinahan J; Rowland M; Lanar DE
    J Clin Microbiol; 1992 Jul; 30(7):1863-6. PubMed ID: 1629344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in the circumsporozoite protein of the human malaria parasite Plasmodium vivax.
    Qari SH; Goldman IF; Povoa MM; di Santi S; Alpers MP; Lal AA
    Mol Biochem Parasitol; 1992 Oct; 55(1-2):105-13. PubMed ID: 1279418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological, immunological and functional properties of two novel multi-variant chimeric recombinant proteins of CSP antigens for vaccine development against Plasmodium vivax infection.
    Shabani SH; Zakeri S; Salmanian AH; Amani J; Mehrizi AA; Snounou G; Nosten F; Andolina C; Mourtazavi Y; Djadid ND
    Mol Immunol; 2017 Oct; 90():158-171. PubMed ID: 28800475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran.
    Zakeri S; Abouie Mehrizi A; Djadid ND; Snounou G
    Trop Med Int Health; 2006 May; 11(5):729-37. PubMed ID: 16640626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.